Hims & Hers Health Inc [HIMS] stock is trading at $18.69, up 4.71%. An important factor to consider is whether the stock is rising or falling in short-term value. The HIMS shares have gain 5.83% over the last week, with a monthly amount glided 18.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on August 22, 2024, when Needham initiated its Buy rating and assigned the stock a price target of $24. Previously, Imperial Capital downgraded its rating to In-line on August 09, 2024. On May 22, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $20 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $15 on April 16, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $20 as its price target on April 10, 2024. Imperial Capital upgraded its rating to Outperform for this stock on February 28, 2024, but kept the price target unchanged to $16. In a note dated February 26, 2024, Leerink Partners initiated an Market Perform rating and provided a target price of $10 on this stock.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $5.65 and $25.74 over the past year. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $18.69 at the most recent close of the market. An investor can expect a potential drop of -14.39% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.07B for the trailing twelve months, which represents a growth of 51.82%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.05 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.79 points at the first support level, and at 16.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.16, and for the 2nd resistance point, it is at 19.63.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 2.68. On the other hand, the Quick Ratio is 2.30, and the Cash Ratio is 1.19. Considering the valuation of this stock, the price to sales ratio is 3.79, the price to book ratio is 11.19 and price to earnings (TTM) ratio is 249.87.
Transactions by insiders
Recent insider trading involved Baird Melissa, Chief Operating Officer, that happened on Oct 07 ’24 when 58750.0 shares were sold. Chief Financial Officer, Okupe Oluyemi completed a deal on Oct 07 ’24 to sell 9868.0 shares. Meanwhile, Officer Melissa Baird bought 58750.0 shares on Oct 07 ’24.
